Verrica Pharmaceuticals (VRCA) announced that it intends to offer and sell shares of its common stock and in either case, accompanying warrants to purchase shares of its common stock, in an underwritten public offering. Jefferies is acting as sole book-running manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRCA:
- Biotech Alert: Searches spiking for these stocks today
- Verrica Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
- RBC downgrades Verrica Pharmaceuticals on ‘uncertain path’ forward
- Verrica downgraded to Sector Perform from Outperform at RBC Capital
- Verrica Pharmaceuticals: Financial Struggles Amid Strategic Shifts